A protein-based therapeutic for human cytomegalovirus infection
AUTOR(ES)
Jean, François
FONTE
The National Academy of Sciences
RESUMO
Current antiviral strategies target viral gene products. Although initially successful, their severe toxicity and susceptibility to circumvention by the generation of drug-resistant variants limit their usefulness. By contrast, the central role of the host cell serine endoprotease furin in the proteolytic activation of numerous pathogens points to the endoprotease as a strategic target for therapeutics. Herein, we show that the production of infectious human cytomegalovirus is dramatically reduced by exogenous addition of a bioengineered serpin, α1-PDX. This protein is a potent and selective furin inhibitor (Ki = 0.6 nM) and is 10-fold more effective than currently used antiherpetic agents in cell-culture models. The requirement of furin for the processing of envelope glycoproteins from many pathogenic viruses and for the activation of several bacterial toxins suggests that selective inhibitors of furin have potential as broad-based anti-pathogens.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=16021Documentos Relacionados
- Engineering a signal transduction mechanism for protein-based biosensors
- A Novel Fluorescent Protein-Based Biosensor for Gram-Negative Bacteria
- Diagnosis of Oropouche Virus Infection Using a Recombinant Nucleocapsid Protein-Based Enzyme Immunoassay
- A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels
- Prions in Saccharomyces and Podospora spp.: Protein-Based Inheritance
